Rnf43tm1.1Npa
Targeted Allele Detail
|
|
| Symbol: |
Rnf43tm1.1Npa |
| Name: |
ring finger protein 43; targeted mutation 1.1, Novartis Pharma AG |
| MGI ID: |
MGI:6724095 |
| Synonyms: |
Rnf43lox |
| Gene: |
Rnf43 Location: Chr11:87553913-87626365 bp, + strand Genetic Position: Chr11, 52.17 cM
|
| Alliance: |
Rnf43tm1.1Npa page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:236636
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site was inserted into intron 5 and a second loxP site into intron 7. The loxP sites are approximately 1.3 kb apart and flank RING domain coding exons 6-7. The FRT site flanked neomycin resistance gene cassette that was also inserted, was removed through subsequent flp-mediated recombination.
(J:236636)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Rnf43 Mutation: |
37 strains or lines available
|
|
| Original: |
J:236636 Planas-Paz L, et al., The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Biol. 2016 May;18(5):467-79 |
| All: |
1 reference(s) |
|